SWX:MOVEMedical Equipment
Does Medacta Group’s Growth Guidance and Innovation Push Strengthen Analyst Confidence in SWX:MOVE?
Medacta Group SA recently reported strong half-year earnings, with sales reaching €344.14 million and net income rising to €60.04 million, while confirming 2025 guidance targeting 16% to 18% revenue growth in constant currency.
Alongside these financial results, the company continued to expand its Personalized Sports Medicine Portfolio, launching the QuickStitch device at a major industry congress, highlighting ongoing investment in innovation and physician education.
We'll examine how...
